Yupo Ma, M.D., M.S., Ph.D.
Director of Flow Cytometry, Chief of Hematopathology
Professor, Department of Pathology
yma@nvcancer.org
Yupo Ma, M.D., M.S., Ph.D., joins us from the University of Arkansas Medical School where he was Director of Flow Cytometry, Hematopathologist and Assistant Professor in the Department of Pathology.
Dr. Ma earned his Medical Degree from Jinan University (P.R. China), College of Medicine and a Ph.D. from the University of South Alabama College of Medicine. He was a Resident in Pathology at Brown University, a Clinical Fellow of Hematopathology at M.D. Anderson Cancer Center and has conducted Post Doctoral Training in Pathology at Harvard Medical School. He is certified by the American Board of Pathology.
Dr. Ma’s research interests include targeting approaches to study human homeotic gene function in human development and human cancer. His research is funded by a National Institutes of Health (NIH) grant.
Ma’s Progenitor Cell Lab
Publications
Ma Y, Wei C, Yang J, Qu J, Di C , Amin HM, Lai R, Ritz J, Krause DS, and L Chai. SALL4, a novel oncogene, is constitutively expressed in acute myeloid leukemia (AML) and is sufficient to induce AML in transgenic mice. 2006, Blood,Oct 15;108(8):2726-35.
Zhang J, Tam W, Tong GQ, Wu Q, Chan BS, Lou Y, Yang J, Ma Y, Chai L, Ng H, Lufkin T, Robson P and B Lim. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. 2006 Nature Cell Biology, Oct;8(10):1114.
